Science method

Biotransformation - Science method

Biotransformation is the chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
Questions related to Biotransformation
  • asked a question related to Biotransformation
Question
12 answers
Hello! I am currently working on my thesis on mercury bioremediation using bacteria. To assess whether biotransformation has occurred, I would like to seek your recommendations for simple analytical methods to determine if the transformation of mercury has taken place by the bacteria. I am looking for a straightforward and commonly available method, as more sophisticated analytical techniques may not be available in my location. Thank you in advance for your response!
Relevant answer
Answer
A simple analysis to confirm if biotransformation of mercury has occurred includes:
1. Total Mercury vs. Methylmercury Analysis:
• Measure total mercury (Hg) and methylmercury (MeHg) concentrations using techniques such as cold vapor atomic absorption spectroscopy (CV-AAS) or inductively coupled plasma mass spectrometry (ICP-MS).
• An increase in the proportion of methylmercury relative to total mercury suggests microbial methylation.
2. Speciation Analysis Using Chromatography:
• Gas Chromatography (GC) coupled with Mass Spectrometry (MS) or Atomic Fluorescence Spectroscopy (AFS) can be used to differentiate inorganic mercury (Hg²⁺) from organic mercury species (MeHg, ethylmercury, etc.).
• If methylmercury or other organic forms are detected, biotransformation has likely occurred.
3. Volatile Mercury Detection:
• Gold amalgamation with CV-AAS or GC-MS can detect elemental mercury (Hg⁰) in the headspace of microbial cultures, indicating microbial reduction of Hg²⁺ to Hg⁰.
4. Colorimetric or Fluorescence-Based Mercury Sensors:
• Some biosensors and chemical assays can detect specific mercury species, providing qualitative or semi-quantitative confirmation of biotransformation.
These methods allow for a straightforward confirmation of mercury biotransformation in environmental or laboratory settings.
  • asked a question related to Biotransformation
Question
6 answers
Hello! I am currently doing my thesis on mercury bioremediation using bacteria. To understand the underlying mechanisms, I'm seeking your recommendations for suitable analytical techniques. I'm particularly interested in investigating processes like biodegradation, biotransformation, absorption, and adsorption. My current proposals include Scanning Electron Microscopy - Energy Dispersive X-Ray Spectroscopy (SEM-EDS) to examine bacterial-mercury interactions, Atomic Absorption Spectroscopy (AAS) to assess mercury transformation, and UV-Vis Spectrophotometry to quantify mercury removal.
Relevant answer
Hello,
Your analytical approach covers a broad spectrum, and the techniques you've proposed are highly effective for understanding different aspects of mercury bioremediation.
Here are a few additional methods to complement your research:
  1. X-ray Photoelectron Spectroscopy (XPS): This can help identify oxidation states of mercury on bacterial surfaces, providing insight into biotransformation and adsorption processes.
  2. Fourier-Transform Infrared Spectroscopy (FTIR): Useful for characterizing functional groups involved in mercury binding on the bacterial surface, helping to clarify absorption and adsorption mechanisms.
  3. Inductively Coupled Plasma Mass Spectrometry (ICP-MS): Ideal for highly sensitive quantification of mercury at low concentrations, and it can also analyze mercury in complex matrices if required.
  4. High-Performance Liquid Chromatography (HPLC) coupled with UV or fluorescence detectors: For examining mercury speciation in solution, this technique can differentiate between organic and inorganic mercury, revealing pathways of biotransformation.
These methods can provide a deeper understanding of how mercury interacts with bacterial cells and the transformation processes it undergoes.
  • asked a question related to Biotransformation
Question
3 answers
Hi everyone,
I'd like to better separate two close peaks coming from a bioconversion sample, I'm currently using a C18 KromaPhase 4,6mm Ø.I. SCHARLAU, particle size (µm): 10, pore size (Å): 100, length (mm): 250, internal Ø (mm): 4,6, with 10/90% acetonitrile/water (0.1% formic acid) as mobile phase at the temperature of 20 °C. I've also tried with 5/95% ACN/water as mobile phase obaiting a better separation, but I've read that is not very good to work with a organic percentage lower than a 10%. I'm open to any suggestion to improve my hplc method. Thank you
Relevant answer
Answer
We really do not have enough information to provide specific suggestions for analysis. Does your sample have mild to strong chromophores ? If so, use a scanning diode-array detector inline for detection. Change the column to one that has a particle size of 5 microns for better resolution. Your isocratic mobile phase is VERY weak. To improve resolution of actual sample peaks, proper HPLC method development must be undertaken. Generic advice may include: Use a gradient HPLC method starting at 5% organic increasing to 95% organic (i.e. ACN) over time. Hold at 95% organic to insure all samples have eluted off the column. Review the results. Is retention found for the compound(s)? Does the K prime of the sample show adequate retention? Is the peak shape Gaussian? HOw many peaks were detected? What do their UV/VIS spectra look like? Etc. Do this following good chromatography fundamentals Please contact a local, experienced chromatographer to assist you.
  • asked a question related to Biotransformation
Question
3 answers
  1. I work on producing organic fertilizer from rice husk. how can I reduce the bio-conversion time ?less than two months
Relevant answer
Answer
To accelerate the bioconversion of rice husk into organic fertilizer in less than two months, strategies include mechanical processing to increase surface area, microbial inoculation with lignocellulolytic fungi, nutrient additives to support microbial growth, vermicomposting to enhance decomposition, and maintaining optimal moisture, temperature, and aeration conditions during composting.
  • asked a question related to Biotransformation
Question
3 answers
Hello,
I am in search for papers that:
1) explain with graphs the biotransformation of diosgenin to cortisone.
2) explain with graphs the biotransformation of soybean oil to progesterone.
If there are DOIs or any the likes than please send it over.
Thank you for your assist
Relevant answer
Answer
Danial Bahroz Tahir It's not my field at all, but I found several papers on your Q1 and a few on Q2 with a simple Google search. I presume you have looked at these?
  • asked a question related to Biotransformation
Question
1 answer
I am trying to investigate the process of biotransformation of plant materials using insect larvae. Is it necessary for delignification process be first carried out?
Relevant answer
Answer
In most of the biotransformation, it is NOT necessary when using an unprocessed as a whole biocatalyst, while using isolated enzymes during biotransformation delignification may be preferable
  • asked a question related to Biotransformation
Question
3 answers
My compounds is choloro benzaldehyde and it is insoluble in water , i am willing to do biotransformation in LB (Lysogeny Broth )media , what should i do?
Relevant answer
Answer
Dimethyl formamide (DMF) is a good solvent to dissolve most organic compounds. I suggest you make a stock solution of 100 mg/mL in DMF then add 20 to 50 uL (i.e. 2-5 mg) into the 50 mL grown microbial culture for its biotransformation. Try this hope you will get it biotransformed.
Good luck,
Faheem Khan
  • asked a question related to Biotransformation
Question
1 answer
My compounds is choloro benzaldehyde and it is insoluble in water , i am willing to do biotransformation in LB (Lysogeny Broth )media , what technique might be useful which doesn't affect yeast cells also?
Relevant answer
Answer
I suggest ethanol or DMSO.
  • asked a question related to Biotransformation
Question
3 answers
For a drug that is practically insoluble in water and sparingly soluble in ethanol and DMSO, how may each of the following factors be manipulated to maximize the drug exposure when applied into a sustained-release injection (parenteral or IV) formulation?
  • particle size distribution
  • API crystal form (anhydrous/monohydrate) -> any effect?
  • suspension solution (aqueous/oil)
  • route of administration (SC/IV/IM)
  • metabolizing enzyme induction/inhibition (CYP/UGT)
Relevant answer
Answer
There's probably no one recipe for all drugs. I think it's pretty consistent that an amorphous form, if you can obtain it, is more rapidly soluble, and that smaller particles dissolve more quickly (due to the larger surface area), but the other factors will vary from one drug to the next. You don't specify if you're relying on low (slow) solubility for the sustained release effect.
  • asked a question related to Biotransformation
Question
3 answers
I am working with some new drugs and looking for biotransformations. We have done the MS/MS of drug-treated bacterial lysates and found the presence of some signature masses matching the fragments of the mother drug, so we are assuming that it can be the biotransformation of the mother drug.
We have a list of m/z and need to deduce the structure from it.
I have used Agilent QTOF.
Can anyone suggest that how can we do that?
I have used SIRIUS but not helpful.
Relevant answer
Answer
Great question, thanks for asking.
  • asked a question related to Biotransformation
Question
5 answers
As we know numerous lignocellulosic biomass (such as forestry residue, crop residue, industrial products, food wastes, etc) have been used in bioconversion research studies but my question is how much type of lignocellulosic biomass we choose as raw material affect the efficiency of the process and should a particular type emphasized more?
Relevant answer
Answer
I would like to add to previous answers that salts containing sodium, potassium, magnesium and calcium are the major minerals found in biomass ash, these elements are part of the alkali and alkaline earth metals (AAEM). For example, during pyrolysis, these minerals, especially AAEMs, act as catalysts and possess a great potential to alter the resulting bio-oil composition. The feedstock could be pretreated prior to pyrolysis to reduce its ash content.
  • asked a question related to Biotransformation
Question
7 answers
Dear colleagues,
in your opinion, what is an appropriate tool to model biotransformation processes in silico. Optimally, the system should predict metabolites and define the involved phase I and II enzymes. Thereby, it would be handy if the tool is user friendly. Hence, it should not require absolute expertise in the involved biochemistry processes.
Any input is very welcomed.
Thanks and best regards
Sebastian
Relevant answer
  • asked a question related to Biotransformation
Question
4 answers
I obtained 2 compounds after a biotransformation reaction. I have isolated the compounds using column chromatography and have characterized them. I need to calculate the yield of the compounds.
Relevant answer
Answer
Please check the attached manuscript. You can use the equation to calculate the % yield mentioned in the attached file.
  • asked a question related to Biotransformation
Question
18 answers
We started a new Podcast focusing on Biocatalysis and Biotransformations. The idea is to interview all invited speakers and keynote speakers of the upcoming Biotrans 2021 in Graz.
We would be very interested in your critique, comments, questions, or suggestions.
Check it out here or at the Podcast platform of your choice: https://anchor.fm/in-the-active-site
Relevant answer
Answer
Next one up. This time we had a great discussion with Nick Turner
  • asked a question related to Biotransformation
Question
4 answers
I am studying arsenic biotransformation by bacteria and I need to check the morphological changes on the bacterial cells after exposure to arsenic. I also need to check if there's any arsenic accumulation or adsorption in the bacterial cell. How can I best prepare my sample for this purpose? We don't have critical point drying machine here so is there any other alternative to this? Thank you.
Relevant answer
Answer
First better to detect quantitatively any accumulation of Arsenic than perform analysis. For detection you need to use about 20-80mg of cells digestion in HNO3.
  • asked a question related to Biotransformation
Question
5 answers
Hi, I've been looking for literature regarding the production of metabolites that are produced primarily by the host and then biotransformed by Lactobacillus to antifungal compounds. Does anyone has seen something like that? Thanks!
PD. An example would be this article:
  • asked a question related to Biotransformation
Question
15 answers
In our country, a lot of water sources are found to be contaminated with arsenic (As). But, here, experts said that, using arsenic contaminated water is not harmful for us, we can use it in our daily needs except drinking.
My question is - using arsenic contaminated water for our daily needs, have any risk of bioaccumulation by surrounding biota? Does it have any associated human health risk?
Relevant answer
Answer
Drinking-water containg Arsenic increases the risks of cancer in the skin, lungs, bladder and kidney, as well as other skin changes such as hyperkeratosis and pigmentation changes.The effects on environments include death, inhibition of growth, photosynthesis and reproduction, and behavioral effects. Environments contaminated with arsenic contain only a few species and fewer numbers within species. If levels of arsenate are high enough, only resistant organisms, such as certain microbes, may be present. If arsenic poisoning occurs over a brief period of time, symptoms may include vomiting, abdominal pain, encephalopathy, and watery diarrhea that contains blood. Long-term exposure can result in thickening of the skin, darker skin, abdominal pain, diarrhea, heart disease, numbness, and cancer.
  • asked a question related to Biotransformation
Question
4 answers
Chromium is one of the main chemical ingredients of tannery industries. Those industries also produce a lot of chromium contaminated solid wastes. what are the biotransformation and bioaccumulation procedures it follows to expose in human body?
Relevant answer
Answer
Have a look at this useful RG link.
  • asked a question related to Biotransformation
Question
8 answers
How I delignified of the cellulose? Which chemical are suitable to delignification?
Relevant answer
Answer
I also have the same question. Besides, what is difference between NaOH and NaClO2 in removing lignin?
  • asked a question related to Biotransformation
Question
4 answers
In preeclamptic or eclamptic patients with significantly decreased liver and kidney functions, can we temporarily use a positive cardiac inotrope or a vasopressor to increase blood flow to these organs to help prevent decreased biotransformation and renal clearance? If so, how can left ventricular hypertrophy can be prevented? Can we use renin-angiotensin-aldosterone antagonists such as enalapril or a cardiac beta 1 selective blocker postpartum?
Relevant answer
Answer
  • asked a question related to Biotransformation
Question
2 answers
I ask because I am a grad student researching microbial plastic biotransformation and I would like to work on polyethylene due to its ubiquity, but recognize it may be more practical to address plastics for which the key enzymes are more established.
Relevant answer
Answer
Hi Nelson,
You are right, the biodegradation of PET and PU is much better established. This is largely due to the presence of ester bonds in their chemical structure, which makes them substrates of different types of esterases. Despite this, they are still difficult substrates for biological degradation. Polyethylene, polypropylene and PVC are even more recalcitrant. Their biological degradation is more difficult compared to the others and therefore not a realistic goal of P4SB.
Hope that helps.
Best regards,
Jose
  • asked a question related to Biotransformation
Question
14 answers
Hello all, I am working on one of the flavour molecule producing it through biotechnological route. I have two recombinant genes that are involved in the enzymatic reaction that are transformed in E.coli Bl21. While setting the biotransformation reaction with the substrate along with the whole E.coli cells and lysed cells, whole cells are giving me better conversions as compared to lysed cells. My question is when i am using the fresh whole cells its conversion is less as compared to the cells resuspended in phosphate buffer ph7 and then stored at 4C (refrigerator) for one two weeks. why?
Relevant answer
Answer
hi
i dont know this answer help you or not, but according to my research , the enzymatic depend on concentration of substrate and enzyme , while temperature decreases , because cell is following osmotic pressure , for low temperature the concentration of substrate and enzyme increases , maybe your answer lie down in temperature dependent .
  • asked a question related to Biotransformation
Question
5 answers
please if you have any publication on this question you can add it to the answers. Thanks
Relevant answer
Answer
@Muna please do share them. Thanks in advance
  • asked a question related to Biotransformation
Question
4 answers
I like to collaborate with your project group on Biocatalysis and biotransformation of vegetable oils to alkyl esters. Could you please assist this collaboration by sharing essential research materials to the scope.
Regards
Mustapha
Relevant answer
Answer
Hi Tejo,
I am still expecting your message.
Regards,
Mustapha
  • asked a question related to Biotransformation
Question
3 answers
I am working on my thesis work, hepatic biotransformation of some biactive compounds extracted from natural products in rat microsomal fraction (S9), for which I need to know the possible enzymatic reactions that will happen and the probable structures of the metabolites.
Relevant answer
Answer
The body produces a steady stream of metabolic waste products (ammonia, bilirubin, urea, lactic acid, etc.)
along with toxic byproducts called – exotoxins - as a result of microbial activity in the human intestine. Continual exposure to toxins originating from both within the body and outside the body gives credence to one of the body’s most vital functions – hepatic biotransformation. The sole purpose of the biotransformation process is to convert toxic compounds into non-toxic, water-soluble compounds which can easily be eliminated. The liver (hepatic) is the key player
in this process.
Detoxification - for many years the term “detox” referred to breaking free of alcohol or drug addiction. Nowadays,
detox means removing all toxins from the body; not just poisons from substance abuse, but also heavy metals, chemical additives, and other toxins found in our food, water and air. As well as the metabolic waste products produced by the body.
Biotransformation - is defined as a metabolic process whereby chemical modifications or alterations are made by the body of a specific chemical compound, usually by means of enzymatic activity. As mentioned these chemical compounds originate either from within the body, usually the result of metabolic waste and are called endogenous compounds or they come from outside the body and are called exogenous compounds.
  • asked a question related to Biotransformation
Question
3 answers
I want to interpolate the amount of product formed (as concentration or % of conversion) vs reaction time in a biocatalysis process. The fitting equation should have as (y) the amount of product and as (x) the reaction time. I thought to use as the fitting equation the integrated form of the M&M but I am not able to find the correct mathematical form. Or should I use another equation?
Relevant answer
Answer
Without any knowledge about the experiment parameters i can only guess which equation might suit your problem.
Having the product [P] as (y) results in some pretty ugly equations most of the time. I'm assuming no inhibitory effects.
[P] = [S]° - Km * W { X }
or alternatively (for the amount of conversion)
[P]/[S]° = 1 - Km/[S]° * W { X }
where [P] is the concentration of product P and [S]° is the initial concentration of the substrate S.
W is the Lambert-W function (or prodlog). You can try
X = [S]°/Km * exp[ ([S]°-vmax*t) / Km ]
as an argument for that function. I hope your program can fit this prodlog-function.
  • asked a question related to Biotransformation
Question
3 answers
Biotransformation
Relevant answer
Answer
Dear Santosh,
Ozone is not "present in the uppermost layer of the atmosphere": its concentration peaks in the stratosphere, which is indeed higher up than the troposphere, but there are other atmospheric layers at even higher altitudes. For an introduction to the structure of the atmosphere, see https://en.wikipedia.org/wiki/Atmosphere_of_Earth#Principal_layers, and for an initial perspective on the vertical distribution of ozone in the atmosphere, see http://paoc.mit.edu/labweb/notes/chap3.pdf.
Inert chemical compounds do indeed exhibit vertical profiles that smoothly decrease with height, like CO2, for instance. However, ozone is a chemically active substance: it is continuously 'created' and 'destroyed' in the stratosphere, due to a set of chemical reactions between the molecules present in that layer and stimulated by ultraviolet solar radiation. The observed vertical profile is the net result of these chemical reactions, combined with the specifics of the stratospheric circulation of the atmosphere, which is rather decoupled from that of the troposphere.
There is a large literature on the dynamics and chemistry of the atmosphere: you will find many relevant sources by searching for these keywords on the Internet.
Good luck in your investigations, Michel.
  • asked a question related to Biotransformation
Question
1 answer
As an instruction based experiment for undergrad class, I am looking for simplest experiment design for above mentioned process 
Relevant answer
Answer
Hi Sonika,
The simplest way would be to use Baker's yeast to convert sugar to ethanol.
Good luck,
Jim
  • asked a question related to Biotransformation
Question
2 answers
Hi all,
One widely accepted rule in biochemistry/pharmacology is that biotransformation is require for compounds with logD>=1 at pH = 7.4. Are there any known cut-offs that do not rely on the logD but other physico-chemical properties?
Thanks,
Yannick
Relevant answer
Answer
Hi David,
Thank you very much for your answer. The paper is a good one. A big question in metabolism prediction is at one point to be able to predict when a compound is phase II-ready or even whether it needs phase II (which most xenobiotics need). I guess at this point, most of these questions need to be answered by a collection of machine learning models.
Thanks,
Yannick
  • asked a question related to Biotransformation
Question
1 answer
I've found, through literature review, that the major product of CYP3A4 coumarin hydoxylation is 3-hydroxycoumarin rather than 7-hydroxycoumarin, the major product of human coumarin metabolism. I know that 7-hydroxycoumarin is glucoronidated and excreted in urine, but is 3-hydroxycoumarin also glucoronidated? I've found a source that says all hydroxylated coumarins are glucoronidated, but I've yet to see a paper that actually discusses glucoronidation of 3-hydroxycoumarin, nor have I found the compound through chemical suppliers like Sigma, which leads me to believe 3-glucoronidation might not typically occur.
Relevant answer
Answer
This paper claims that neither 3-HC nor 3-HC glucoronide have been observed as products of human liver microsomal activity on 7-ethoxycoumarin.
  • asked a question related to Biotransformation
Question
2 answers
I am working on the effect of lodging in rapeseed.Now I want to check enzymes in green pods
Relevant answer
Answer
please check phenylalanine ammonialyase, cinncamyl aldehyde dehrogenase, peroxidase
then phenol and lignin levels
  • asked a question related to Biotransformation
Question
1 answer
Thanks in advance.
Relevant answer
Answer
I am not very familiar with that issue, but for other reasons I am more familar with serratia and I have a reference that might be useful for you... good luck 
Exp Ther Med. 2015 Mar;9(3):795-800. Epub 2014 Dec 18.
Cloning and sequence analysis demonstrate the chromate reduction ability of a novel chromate reductase gene from Serratia sp.
Deng P1, Tan X2, Wu Y1, Bai Q1, Jia Y1, Xiao H1. 
  • asked a question related to Biotransformation
Question
2 answers
Any advice on Cytochromes P450 (CYP) panel on chemotherapy? What's your gene list? Clinically, Roche got an FDA-approved panel but is outdated and limited - do you have an updated list?
Cytochromes P450 (CYP) are a major source of variability in drug pharmacokinetics and response. Of 57 putatively functional human CYPs only about a dozen enzymes, belonging to the CYP1, 2, and 3 families, are responsible for the biotransformation of most foreign substances including 70–80% of all drugs in clinical use. The highest expressed forms in liver are CYPs 3A4, 2C9, 2C8, 2E1, and 1A2, while 2A6, 2D6, 2B6, 2C19 and 3A5 are less abundant and CYPs 2J2, 1A1, and 1B1 are mainly expressed extrahepatically.http://www.sciencedirect.com/science/article/pii/S0163725813000065
Relevant answer
Answer
Hi Shengwen,
Replying to your question regarding CYP panel on chemotherapy, it's very important to keep in mind that even within an FDA-approved panel one must operate with pre-assessment of, say, each individual intra-tumor expression of CYP and its monooxygenase activity towards the drug used. The latter pattern is major source of variability in drug pharmacokinetics and response. For instance, early studies by Patterson et al. (1995) identifying  P450R as a key player in tirapazamine bioactivation. This evidence came from studying the in vitro sensitivity of breast tumor cell lines to tirapazamine that exhibited an inherent 6-fold range in the CYP activity. Using short exposures (3 h) to tirapazamine, the level of P450R correlated strongly with the extent of tirapazamine toxicity in hypoxic conditions. However, aerobic sensitivity was also measured following both short-term (3 h) and prolonged (96 h) exposures to tirapazamine and was also shown to be dependent on P450R activity.
Besy wishes,
Ilya
  • asked a question related to Biotransformation
Question
3 answers
Actually I am working on the biotransformation of cyclopentanol to cyclopentanone by using an alcohol dehydrogenase and also I am working on the biotransformation of cyclopentanone to cyclopentanol as well . 
I know that the best way to determine the product is GC-MS but as it costs a lot so before the GC-MS I want to get sure of the product formation by using TLC.
Relevant answer
Answer
Yes, sure! TLC would work. Try cyclohexane: ethylacetate (9:1) as mobile phase on silicaagel TLC F 254 plates and use iodine vapor or even H2SO4 spray to get the two product separated and even quantified- should be perfect for separation of an alcohol and a ketone! Thanks, Biswa
  • asked a question related to Biotransformation
Question
6 answers
Can someone help or explain which may cause differences in processes of drug excretion from the organism of rats and mice (rat -fecal excretion of the drug predominated (70%), mice - excretion proceeded with equal efficiency in urine and feces). The drug is practically (80%) are not biotransformed, minor reactive metabolites are equally in rat and mice.
Relevant answer
Answer
Hi Olga.
Unfortunately you did not specify the name of the drug, or even designated the route of its administration, So, its impossible to help you with excretion data analysis and interpretation. In the given circumstances, your drug’s data looks similar to those characterizing the excretion of octoclophelin. To make comparisons (and take some useful information), please see the results published by Z. Franc et al. in Biochemical Pharmacology, Volume 19, Issue 4, April 1970, Pages 1443-1448. In a nutshell, Octoclothepin is absorbed well from the intestinal tract of mice; while in rats, absorption is slow. If given intravenously, highest concentrations of the drug were found in the kidneys and in the lungs and the lowest in the spleen, skin and muscle. Elimination is slow and depends on the route of application and on the animal species. The urine of rats treated with 35S-octoclothepin contained 35S-octoclothepin, 35S-octoclothepin sulphoxide, 35S-sulphate, 35S-sulphate esters and unidentified metabolites. Twenty per cent of the intravenously administered 14C-(methyl)-octoclothepin was eliminated as 14CO2.
Best wishes,
Ilya
  • asked a question related to Biotransformation
Question
2 answers
My previous attempt to raise this point was misdirected to the data on hydrophobic zone(s) in protein moiety of P-450 (CYP) influencing its active center’s substrate-binding and catalytic efficacy. In other words, membranous localization of monooxygenases is commonly ignored thus considering enzyme-kinetics of P450s as any other water-soluble enzymes. Inasmuch as the vast majority of modern medicines belonging to P45O substrates are relatively to highly lipophilic, and any pharnacy prescription drug information sheet contain data on drug-drug interactions, which occur at P450 active site, drugs' octanol-water partition coefficients (log P, by definition made by Hansch & Leo) values should be taken into calculations of Ks, Km, Vmax, Kcat, etc.
Nowadays, thirty years since we discussed the very point with Dr. Walter Pyerin of German Cancer Research Center, Heidelburg, his conclusions still sound very actual: “When the fluidity of the membrane was changed showing a well-defined gel to liquid crystalline phase transition, the activation energy of the monooxygenase reaction was changed at around the phase transition temperature, suggesting a conformational change of cytochrome P-450 caused by the fluidity change of the membrane. The incorporation of P-450 into liposomes was also found to affect the binding of substrates to cytochrome P-450. The decrease in the apparent dissociation constant of substrates upon incorporation into membranes suggests that the lipid membrane acts as a pool for hydrophobic substrates, which are concentrated in the lipid phase, and that cytochrome P-450 takes substrates directly from the membrane phase. Phospholipid membranes, therefore, play very important roles in various phases of the reaction of cytochrome P-450-dependent monooxygenase” (H. Taniguichi & W. Pyerin, Phospholipid bilayer membranes play decisive roles in the cytochrome P-450-dependent monooxygenase system. J Cancer Res Clin Oncol 114: 335-340, 1988).
Relevant answer
Answer
Yes, Dr. Shapiro, there is almost perfect accuracy in approximation of octanol:water partition coefficient (logP) to distribution of a lipophilic P450 substrate between water compartment of the cell and its phospholipid-enriched endoplasmic reticulum membrane.  It has been, alongside with others, shown, for a example,  in our paper published in The Biochemical Journal,  160:75-83, 1976, in our survey:  “Role of microsomal phospholipids in organizing and regulating the activity of a monooxygenase system” (Biological Reviews, 84:3-21, 1977), as well as in my (with Dr. Lyachovich) monograph entitled “Structural Aspects of Monooxygenases Biochemistry” (Science Press, NAUKA, 337 pp, 1978).
Since then, many data were published describing the crucial role of microsomal phospholipids in a substrate binding and metabolism at P450 (CYP) active site.  Thus in  Toxicol In Vitro.18(1):89-97, 2004, D. Lewis published a paper “Quantitative structure-activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymes”, where substrate lipophilicity was determined of key importance to P450 binding affinity and enzyme selectivity. From an extensive compilation of log P values for P450 substrates, and by analysis of relationships between partitioning energy and substrate-binding free energy, the relevance of lipophilicity and other factors pertaining to P450 binding affinity was explained, leading to the formulation of lipophilicity relationships within substrates of each human P450 enzyme involved in drug metabolism. Furthermore, log P values for P450 substrates appear to represent markers for enzyme selectivity. Together with the important roles of hydrogen bonding and pi-pi stacking interaction energies, the desolvation of the P450 active site makes a major contribution to the overall substrate-binding energy.
LogP values become even of greater importance after revelation and dramatic developments (both in academic research and clinically-applied areas) of drug-drug interactions at CYP active site. Thus, among many recent data of others, Yi-Ting Zhou et al. presented a paper “Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management”, published in “Ther Clin Risk Manag. 10: 17–26, 2014). They studied phisico-chemical and enzyme kinetic parameters of coadministration of 1,4-dihydropyridine calcium channel blockers (DHP-CCBs) with statins reductase inhibitors, which is common for patients with hypercholesterolemia and hypertension. Authors investigated the inhibitory effects of 13 kinds of DHP-CCBs on human CYP-isoenzyme-dependent reactions using microsomes from human B-lymphoblast cells expressing CYP. Interestingly, lipophilicity was found to be an important factor in the strength of the pharmacokinetic interactions of DHP-CCBs. The logarithm of the molecular 1-octanol-water partition coefficient (logP) values indicated significant positive correlations with the interaction strength.
  • asked a question related to Biotransformation
Question
4 answers
I like to use e.coli cells (pellet) in buffer, which should convert a aromatic and low water soluble molecule. Could DMSO  help to overcome the transport limitation ? 
Or have someone expericence with digitonin e.g. ? http://en.wikipedia.org/wiki/Digitonin
Relevant answer
Answer
Thank you, for your nice inputs!
  • asked a question related to Biotransformation
Question
3 answers
When fungi is used to pretreat the lignocellulosic biomass, the mycelial mat is grown over it. It has to be separated from the mat so that the substrate can be used for further bioconversion steps. How is it done?
Relevant answer
Answer
Karim sir, how do you inactivate it? Can I just autoclave it if it has to be sterilized for further use?
  • asked a question related to Biotransformation
Question
3 answers
I am isolating bacteria degrading lignin on agar plate. I found one bacteria turn the lignin plate into dark quickly while the bacteria do not turn TSA or LB plate into dark.   What is the mechanism for turning lignin into dark? That plate is made of lignin and some salts (Bushnell-Hass medium).  What do you think is an indicator of good lignin-degrading bacteria? 
Relevant answer
Answer
Just a query, if the bacteria was spread all over the plate or streaked ? Or bacteria was put into holes. I mean, did the bacteria come in contact with whole of the lignin-plate and the entire plate turned black ? Lignin must be brown, and further browning (dark) means oxidation of phenolic moieties in lignin making them brown- thus the bacteria must have "oxidase" activity. Alternatively, the lignin was degraded by bacteria (with "ligninase" activity) thus breaking the ligning into monomeric monolignols/phenolics which are autoxidised in presence of "air" only. To check the later event, the same bacteria if fed with only simple phenolics (sinpic acid etc.) must not yield darkening thus indicating absence of oxidase activity and only ligninase activity. Another very distant possibility would be that the bactrial cells are lysed (in contact with lignin) to release some chromophores which are bacterial pigments, or simply bacterial pigments oxidizing to dark ones. I would be interested to know the outcome of further results too. Best wishes. 
  • asked a question related to Biotransformation
Question
13 answers
Usually it is recommended to add glucose after sterilization of media.
Can anyone tell me, then how should we add glucose in the media?
We usually work on litres of media (4 to 8 L), for which we need 30 to 50 g glucose.
If we add solid glucose then there are chances of contamination.
Should we use microfilters?
Microfilters are very expensive.
Then what others?
In our experiments, we do not care how much glucose is oxidizing on heating in autoclave because our concern is to obtain enough growth of the culture for biotransformation.
Relevant answer
Hello, you mention the concentration of glucose is 30-50 g per liter or the total culture medium prepare. You can dissolve the glucose in 150 ml sterile water and filter through a millipore membrane, and that is the medium and add to a sterile laminar flow hood or directly the bioreactor with a peristaltic pump . The second way is : 150 or 200 ml autoclave sterilization at 15 lb / cm2 for 15 min and adicionas to the culture medium . The fact of putting glucose together with the other components of the medium, is primarily nitrogen source as it reacts with compounds forming glucasa inihiben microbial growth ( Maillard reactions ) if your medium does not have high concentrations of amino acids , proteins , ammonium salts put no problem glucose culture medium and esterilices together .
  • asked a question related to Biotransformation
Question
6 answers
I'm looking for any study that found fungal biotransformation of terpenes by the secretions of a fungi grown in agar petri dishes (or any solid substrate). That is, some fungus capable of biotranfsorming terpenes without "touching" them with the hyphae, but biotransform the terpene by secreting some substance (exoenzymes or similar). If you don't know about any study like this on terpenes, may you know about some with other substances? or with bacteria or any other organism?
I've been quite extensively searching about that and by now I have not been able to spot any article like this.
Thank you very much!
Relevant answer
Answer
Hello Ander, the diversity of terpenes imply that there are multiple degradation pathways involved. You may want to have a look at this paper which is specifically looking at limonene degradation:
Wang, Y., Lim, L., Madilao, L., Lah, L., Bohlmann, J., & Breuil, C. (2014). Gene discovery for enzymes involved in limonene modification or utilization by the mountain pine beetle-associated pathogen Grosmannia clavigera. Applied and environmental microbiology, AEM-00670.
I am currently pursuing this work by doing the functional characterization of genes putatively involved in the initial steps of the proposed pathway.
Salutations
Philippe
  • asked a question related to Biotransformation
Question
4 answers
I want detailed examples
Relevant answer
Answer
  • asked a question related to Biotransformation
Question
3 answers
If a drug is biotransformed into a metabolite within 24 hours what will happen to that metabolite?
I used a fungal culture to biotransform a drug. After 24 hours I tested for metabolites using TLC, I got two spots below to the starting. But when I checked the same after 48 hours i didn't get the spots. What may be the reason?
Relevant answer
Answer
There are several possibilities and several questions:
  1. Did you compare it with culture control (without drug) and substrate control (without culture) extracts of same period of incubation?
  2. Did you notice the spot of the drug in the line of 24 hour extract where you found more polar spot? Drug spot was there or not? was it of same intensity or lighter one?
  3. Did you increase the polarity of your eluent for 48 hours sample?
  4. Did you try the co-spot elution of your expected metabolite of 24 hours with your substrate drug?
Despite all that there are several possibilities:
  1. Metabolite may be further metabolized to more polar one, which remain their on the site of spotting in your eluent.
  2. It might undergo a gross structural changes e.g. ring closing, aromatization, or destruction of aromaticity. So the staining reagent is unable to spot it there.
  3. If you are observing under UV then, there is a possibility of hydrogenation in further 24 hours (48 hours), so you couldn't detect under UV. 
  • asked a question related to Biotransformation
Question
6 answers
I am working on polylactic acid production from lactose. After production of lactic acid, is there any biological (microbes/bioenzymes) which can convert it to polylactic acid? Direct conversion of lactose to polylactic acid by microbes is also desirable.
Relevant answer
Answer
To the best of my knowledge there is a (direct) route of polycondensation (but limits in view of the final molecular weight) and/or as already mentioned by Marc the ring opening polymerization starting from dilactide... see e.g. "Current Progress on Bio-based Polymers and Their Future Trends By SpecialChem - August 8th, 2013"
Best regards and Happy 2015, Joachim
  • asked a question related to Biotransformation
Question
3 answers
Biotransformation performed by microbes has advantage over chemical synthesis due to more "green" and higher chiral specificity. Rather than random screen, do you have any ideas to design a higher efficient way to screen bacteria that are potential useful?  For example, to specifically convert C=O to  C-OH, or vice verse. Another example, to add or remove some chemical groups through acting on glucosidic bonds in some carbohydrates. 
Relevant answer
Answer
Hi Daniel,
 Look out for enzymes responsible for your mentioned transformations and then check which microbe produce that enzyme of your interest. OR
You can screen for microbes that produces your enzyme of interest using enzyme screening assays. Most of the enzyme screening assays are already deduced so you can easily find an organism producing your enzyme with all the available infrastructure of your lab. Its all chemistry behind transformations so if you understand that chemistry then you can play with it anyhow. 
Good luck
  • asked a question related to Biotransformation
Question
8 answers
Has anyone worked on nanoparticles using either X-ray absorption near edge structure (XANES) or Synchrotron radiation? I would appreciate an enlightenment on better techniques out of the two to examine biotransformation/speciation of nanoparticles in plant parts after uptake.
Relevant answer
Answer
  • asked a question related to Biotransformation
Question
5 answers
Plant secondary metabolites as thymol and carvacrol undergo glucuronidation and sulfation in liver, intestine and kidney. There are several isoforms of enzymes involved during this phase II of biotransformation.
Relevant answer
Answer
Dear Vladimira
You may get some information on metabolites products and major mecchanism of Thymol and Carvacrol in this attachments.
Thanking you
  • asked a question related to Biotransformation
Question
7 answers
Bio-transformations of natural and synthetic compounds are performed by using a large range of bacteria and fungi.
Can I use a magnetic stirrer for water insoluble compounds; or should I use emulsifying agents for this purpose?
Relevant answer
Answer
I have worked with bioconversion of Progesterone to 11-alpha-hydroxyprogesterone using fungal strains. I used a low concentration of solvent that was tolerated by fungal strains to improve substrate solubility and used a magnetic stirrer to keep the substrate dispersed (I used a 5 Lt Schott bottle as a mini bioreactor in absence of actual bioreactor). Using micronized substrate powder also helped. If you are using a small bioreactor, there should be no problem of keeping substrate dispersed. Uptake will definitely be an issue as others have already indicated, but dispersing or emulsifying agents can help. The challenges could be also in analytical measurements to obtain representative samples. Type of microbial strain you need to use for bioconversion will also be an important issue. I would prefer to use a small bioreactor than shake flasks, if you can avail the facility though. Give it a go, and I am sure you will work it out as I did.
  • asked a question related to Biotransformation
Question
8 answers
I want to design an artificial metabolic pathway in bacteria or just using responsible enzymes to produce certain products such as H2 or other biofuels. Where can I start with? Do you have some thoughts about this? 
Relevant answer
Answer
On of our students made this on E.Coli by inserting genes and blocking some pathways.I'll check if I can find the thesis. 
  • asked a question related to Biotransformation
Question
2 answers
Plant secondary metabolite as thymol undergo sulfation in the liver and other organ tissues. There are several isoforms of enzymes involved during this phase II of biotransformation. Result of this reaction is metabolite - thymol sulfate. 
Relevant answer
Answer
Thyme leaves contain thymol that increases  xenobiotic-metabolizing enzymes. sulfotransferase b,  that might show significantly higher ECOD, GST, and QR activities. 
  • asked a question related to Biotransformation
Question
7 answers
.
Relevant answer
Answer
Dear Rathinam, This is vague question, you know. You perform extensive literature review on this topic.
  • asked a question related to Biotransformation
Question
2 answers
I am using arsenic transformng bacteria for reducing arsenate (V) to arsenite (III) in a soil sample. The soil sample is treated with water for one month. After one month I am analyzing the pH, electrical conductivity and oxidation reduction potential of the soil sample. I would like to know whether these three properties will increase or decrease after reduction of arsenate to arsenite after one month.
Relevant answer
Answer
So, this is a very complicated system that you're looking at, particularly depending on the composition of the soils that you're using. If you're not controlling some of the factors in some way (i.e. - using a buffer to control pH), then one of those factors could be inter-related with the others.
The observed redox potential of a simple system where you're looking at just one metal (in your case, arsenate and arsenite) is dependent on the concentrations of the two and the equilibrium between them, which is also related back to the standard reduction potential of the system through the Nernst equation. In your case, if you were just looking at arsenate and arsenite, as you increase the arsenite concentration (and increase the ratio of reduced to oxidized), the redox potential would become more negative. In addition, if any of the equilibria that are present in the system involve protic species (which is also true for arsenate and arsenite), then protonation constants would come into play in the redox equilibria. There have been a number of studies that have looked at the relationship between Eh (system redox potential) and pH in the past, and they have produced detailed plots of the system speciation when both Eh and pH are varied. These plots are called either Pourbaix diagrams or just "Eh vs pH" diagrams.
Your system may also be slightly more complex since you will have all of the soil components, many of which can have an effect on all three of the system characteristics that you mentioned in your question.
I hope this was helpful!
  • asked a question related to Biotransformation
Question
9 answers
As a person working with biocatalysis in non-standard media I am also interested in solvent/enzyme relationships. It was found that there is a dependance of behaviour of enzymatic preparations in non-aqueous media from the logP (partition coefficient) value. Therefore, I need to find the value for the solvent mixtures I used - namely hexane:THF 7:3 and 1:1. I heard that it is possible to calculate these values - but never found how it is done. Can anyone be of some assistance?
Relevant answer
Answer
Regardless of the problem of logP-calculation, I'd like to advice you to rethink whether you really require this value. It has become obvious for quite some time now, that the results of Laane et al., to which you obviously refer, have only a very limited application range. There actually seems to be a relation between enzyme behaviour and log P as long as you compare solvents of the same type. When comparing solvents with essentially different functional groups logP is not really an option to estimate the enzyme behaviour.
  • asked a question related to Biotransformation
Question
10 answers
I am working on the microbial transformation of triterpenes using A. niger
the microbe was incubated for 24 hrs in 30 c , then 10 mg of the substrate have fed to the microbe.
As a screening experiment I incubated the fungi with the substrate for 2, 4 and 6 days in 3 different conical flasks.
I harvest the and check on TLC, noted that the substrate very slightly or has not consumed at all.
And there was no any marks for any metabolite or transformed product?
Relevant answer
Answer
Yes through this method you would be able to utilize extracellular enzymes. You can also apply a different method. Grow the fungus. Once it is fully grown. Sonicate the culture in the flask. This may burst the cells and intracellular enzyme come out of cells into the medium, which may catalyze the transformation of your compounds.
  • asked a question related to Biotransformation
Question
1 answer
I'm interested in screening lipases for a lactonization reaction. The substrate contains a secondary alcohol and a a carboxylic ester, so effectively looking for a transesterifcation reaction. The desired lactone would form a nine-membered ring. I'm aware of a number of kits available for screening immobilized lipases, but wondering if there is an obvious 1st choice for this type of reaction in an organic solvent. I have only experience using PPL, but this was to make alpha-omega lactones from omega-OH fatty acids(eg. C15-C18), not for internal lactones with substiutuents "beyond" the two reacting groups. Any advice appreciated
Relevant answer
Answer
I would use the same protocol you used for the omega-OH experiments. A problem you should foresee is that cyclization of medieum size rings (8-10 atoms) are very difficult because of the transannular esteric effects. But your goal is a very interesting one. Keep us posted!
  • asked a question related to Biotransformation
Question
8 answers
We already have in place HPLC/UPLC based methods, but these are ' stopped time' based, so tedious for kinetic studies. Looking for a colorimetric assay (eg. enzyme coupled?) that would target the co-product, S-adenosylhomocysteine. Any thoughts appreciated.
Relevant answer
Answer
Correction to the above: A coupling enzyme is required. It is S-adenosylhomocysteine hydrolase (SahH). It can be cloned from the genome of the bacterium Pseudomonas aeruginosa and expressed in E. coli for purification.